Drappa Jorn reported option exercise involving 11,317 shares of ALUMIS INC. at $8.84 for $100k on May 22, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Medical Officer
Chief Medical Officer
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$100,042.28Shares × reported price
Shares traded
11,317Common Stock
Price per share
$8.84Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
43,804Direct
Trade date
May 22, 2026Option exercise
Filed
May 27, 2026, 7:06 PM ET5-day reporting delay
Accession
0001789317-26-000005Code M · Transaction 90760
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 22, 2026Option exercise15,535$5.06$78,607.10Trade 90761
May 22, 2026Option exercise11,317$0.00$0Trade 90762
May 22, 2026Option exercise15,535$0.00$0Trade 90763
4 transaction rows in this filing. Joint filers share the same rows.

ALMS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ALMS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +21%1w ago +7.2%1d ago +3.9%
Returns since7d −5.9%30d +24%90d +11%180d1y

Footnotes in full

F1: Includes 1,037 shares acquired on November 20, 2025 and 3,000 shares acquired on May 20, 2026 under the Issuer's 2024 Employee Stock Purchase Plan. F2: 25% of the shares underlying this option vested on August 22, 2023, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date. F3: 25% of the shares underlying this option vested on February 18, 2026, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.